KMT2C Rekombinanter Antikörper
KMT2C Rekombinant Antikörper für IF/ICC, FC (Intra), ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
IF/ICC, FC (Intra), ELISA
Konjugation
Unkonjugiert
CloneNo.
240542A2
Kat-Nr. : 83595-4-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
83595-4-PBS bindet in IF/ICC, FC (Intra), ELISA KMT2C und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | KMT2C fusion protein Ag28875 |
| Vollständiger Name | myeloid/lymphoid or mixed-lineage leukemia 3 |
| Berechnetes Molekulargewicht | 541 kDa |
| GenBank-Zugangsnummer | NM_170606 |
| Gene symbol | KMT2C |
| Gene ID (NCBI) | 58508 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein A purfication |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Lysine (K)-specific methyltransferase 2C (KMT2C, also known as MLL3) belongs to the mixed-lineage leukemia (MLL) family of histone methyltransferases which methylate the histone 3 tail at lysine 4 (H3K4) as part of the complex proteins associated with Set 1 (COMPASS) complex. Although originally identified as oncogenic fusions in leukemia, genome-wide mutation studies have revealed frequent, presumably loss-of-function, mutations in various members of the MLL family, including MLL2/KMT2B, MLL3/KMT2C, and MLL4/KMT2D in a variety of malignancies, particularly solid tumors. Mechanistic studies of KMT2C in normal cells have focused primarily on its role in enhancer regulation by deposition of H3K4me1 marks.





